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on Oxetan-3-ols: Synthesis of 3,3-Diaryloxetanes and 2,3-
Dihydrobenzofurans
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Abstract: The first examples of 3,3-diaryloxetanes are pre-
pared in a lithium-catalyzed and substrate dependent diver-
gent Friedel–Crafts reaction. para-Selective Friedel–Crafts re-
actions of phenols using oxetan-3-ols afford 3,3-diaryloxe-
tanes by displacement of the hydroxy group. These consti-
tute new isosteres for benzophenones and diarylmethanes.
Conversely, ortho-selective Friedel–Crafts reactions of phe-
nols afford 3-aryl-3-hydroxymethyl-dihydrobenzofurans by
tandem alkylation–ring-opening reactions; the outcome of
the reaction diverging to structurally distinct products de-
pendent on the substrate regioselectivity. Further reactivity
of the oxetane products is demonstrated, suitable for incor-
poration into drug discovery efforts.
Introduction
The use of bioisosteres to replace problematic functionality
whilst maintaining advantageous characteristics is an impor-
tant strategy in drug discovery.[1] The implementation of new
isosteres provides access to novel chemical as well as intellec-
tual property (IP) space, and presents interesting property
modulation of biologically significant groups.[2] Diarylketones
display important biological activity and are prevalent in natu-
ral products (Figure 1).[3, 4] However, their use in medicinal
chemistry efforts suffers from issues of metabolic and chemical
stability due to the electrophilic carbonyl, and lack of appropri-
ate isosteres. Indeed, benzophenones are commonly exploited
as photoactivatable cross-linkers in chemical biology.[5] Similar-
ly, diarylmethane derivatives provide varied biological activity,[6]
for example tesmilifene has shown activity as a chemopotentia-
tor in clinical studies including for metastatic breast cancer.[7]
However, the methylene group can often present a metabolic
liability.[8] The incorporation of blocking substituents, such as
gem-dimethyl groups, can improve metabolic stability, but de-
liver a negative impact on a compounds physicochemical
properties, such as lipophilicity (LogD) and solubility. A similar
motif appears in bisphenol A (BPA), used in bulk as a monomer
in polycarbonates to ensure optically clarity, and in other di-
verse consumer products.[9] This compound is controversial
due to potential interference with the endocrine system and is
banned in baby bottles, for example, in many countries. Due
to these varied functions diaryl motifs have been the subject
of wide ranging synthetic efforts.[10]
Recently, Carreira has presented oxetanes as replacement
motifs for gem-dimethyl and carbonyl derivatives due to similar
spatial properties and lone pair arrangements.[11,12] In drug dis-
covery settings, the incorporation of the polar, low molecular
weight oxetane moiety has often afforded compounds with
enhanced properties such as improved metabolic stability, sol-
ubility and lipophilicity.[13] As part of our interest in the synthe-
sis of novel oxetane derivatives,[14] we were intrigued by possi-
ble approaches to 3,3-diaryloxetanes, designed to provide iso-
steres for diarylketone and diarylmethane structures with im-
proved properties for drug discovery. At the outset of this
work, there were no reported examples of disubstituted 3,3-di-
aryloxetanes in the literature.[15,16] Indeed, internal efforts
Figure 1. Some important benzophenones and diarylmethanes and pro-
posed oxetane replacement.
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within Pfizer corroborated this observation, with this motif
being recognized as difficult to access.
Herein we report the synthesis of 3,3-diaryloxetanes, pre-
pared by a lithium-catalyzed Friedel–Crafts reaction of phenols
with readily accessible oxetan-3-ols. We also disclose an effi-
cient synthesis of 3-aryl-3-hydroxymethyl-dihydrobenzofuran
derivatives using the same conditions, the reaction outcome
being dependent on the regioselectivity of the Friedel–Crafts
reaction. This presents a rare example of a divergent reaction
whereby a regiochemical difference leads to structurally dis-
tinct products, so avoiding closely related isomers.[17]
Results and Discussion
We envisaged that the synthesis of 3,3-diaryloxetanes might
be achieved through a catalytic Friedel–Crafts reaction, directly
displacing a hydroxy group from 3-aryloxetan-3-ols. These sub-
strates would be readily generated by the addition of aryl-
metal reagents to commercially available oxetan-3-one.[11a]
However, this strategy posed interesting questions on the
nature and feasibility of the required carbocationic intermedi-
ate due to the increased p-character of the strained ring
bonds, and the electron-withdrawing nature of the oxygen
atom. To date there were only two transformations to displace
the hydroxy group of tert-oxetanol derivatives, both on aryl de-
rivatives; i) direct OH displacement with diethylaminosulfur tri-
fluoride (DAST) to generate tertiary fluorides and ii) conversion
to the tosylate and reduction with LiAlH4 to form the 3-aryl ox-
etane.[11a] Furthermore, achieving the desired transformation
under catalytic conditions (see Scheme 1), would require the
activation of the hydroxyl group selectively, over coordination
to the Lewis basic oxetane lone pairs[18] and other oxygen con-
taining species, and must prevent ring opening polymerization
of the oxetanes under acidic conditions.[19]
We selected aryl-oxetanol 1 for investigation being likely to
stabilize a carbocationic intermediate, and with the potential
to reveal phenol functionality for further derivatization on
benzyl deprotection (Scheme 1). Inspired by recent develop-
ments of Friedel–Crafts reactions displacing hydroxy groups at
tertiary centers,[20,21] we examined a variety of Lewis acids as
potential catalysts with electron rich aromatic nucleophiles.[22]
We were delighted to observe that both calcium triflimide
with Bu4NPF6 additive, as reported by Niggemann,
[21] and lithi-
um triflimide/Bu4NPF6 successfully formed the 3,3-diaryloxe-
tane 2a using excess phenol on heating at 40 8C in chloroform.
This oxetane product was formed exclusively as the para-sub-
stituted phenol derivative, in a ratio of around 2.5:1 with
a minor product. Intriguingly, the minor product was identified
as 2,3-dihydrobenzofuran 3a resulting from reaction at the
ortho-position and oxetane ring opening. The two heterocyclic
products 2a and 3a were readily separated by flash column
chromatography to give structurally distinct compounds. This
suggested the potential for an unusual substrate controlled
structurally divergent reaction based on the phenol regioselec-
tivity.
To investigate and optimize the parameters of the reaction,
a design-of-experiments (DOE) approach was adopted, and
was conducted for both Ca and Li catalysts.[22] Temperature,
concentration, catalyst and additive loading, equivalents of nu-
cleophile and reaction time were investigated (see Table 1 for
representative results). Comparable results were obtained with
Ca(NTf2)2 at 5 mol% and Li(NTf2) at 10 mol% loadings (entries 1
and 2). On optimization the best results were achieved using
the Li(NTf2) catalyst (11 mol%) and five equivalents phenol af-
fording a combined yield of 83% for the two products after
1 h (entry 3). The Bu4NPF6 additive was needed, presumably to
solubilize the catalyst, and a 2:1 ratio of Li(NTf2) to Bu4NPF6
gave the best yield (entries 3–5). Increasing the amount of
phenol to 10 equivalents did not result in an improvement. A
decrease in the yield of oxetane product was observed on fur-
ther increasing the catalyst loading to 20 mol% (entry 7). Di-
chloroethane, chlorobenzene and hexane were also suitable
solvents but delivered slightly reduced yields of oxetane (52–
58%). Both Li(NTf2) and Bu4NPF6 are inexpensive and easily
handled powders. Increasing the scale of the reaction to
7.5 mmol gave comparable results, providing >1 g of oxetane
2a (57%) along with dihydrobenzofuran 3a (21%, entry 8). Ox-
etane 2a was stored at room temperature in air for
>6 months without any noticeable degradation.
With optimized conditions in hand, the scope of the reaction
to selectively form oxetane products was investigated. Pleas-
ingly, the use of ortho-substituted phenols gave excellent se-
lectivity for the diaryloxetane products, which were formed ex-
clusively (Scheme 2, <3% dihydrobenzofuran for all examples
Scheme 1. Friedel–Crafts alkylation of oxetane 1 with phenol.
Table 1. Selected optimization for the reaction of 1 with phenol.
Entry[a] Catalyst Cat./
Bu4NPF6
[mol%]
Equiv.
phenol
Yield 2a
[%][b]
Yield 3a
[%][b]
1 Ca(NTf2)2 5/5 3 44 19
2 Li(NTf2) 10/5 3 47 19
3 Li(NTf2) 11/5.5 5 63 (61)
[c] 20 (19)[c]
4 Li(NTf2) 11/- 5 0 0
5 Li(NTf2) 11/11 5 22 6
[d]
6 Li(NTf2) 11/5.5 10 65 21
7 Li(NTf2) 20/10 5 51 20
8[e] Li(NTf2) 11/5.5 5 (57)
[c] (21)[c]
[a] Conditions: 1 (0.25 mmol), CHCl3, 0.5m, 40 8C, 1 h. [b] Yield determined
by 1H NMR using 1,3,5-trimethoxybenzene as internal standard. [c] Yield
of isolated product in parenthesis. [d] 1 recovered in 46%. [e] 7.5 mmol
1 used.
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by 1H NMR of the crude reaction). Electron-rich phenols gave
high yields of diaryloxetanes 2a–c. Electron-withdrawing and
electron-neutral ortho-substituents were tolerated on phenol
(2d–f, h), though reduced yields were obtained for the halide
examples. This is likely to be due to decomposition of the un-
stable carbocation with lower rates of addition for these nucle-
ophiles. In all cases the starting material was consumed within
the 1 h reaction time. Catechol and 1-naphthol also proved to
be suitable nucleophiles with the diaryloxetanes 2g and 2 i
formed good yield (63 and 44%, respectively). Furthermore, di-
methoxybenzene provided an example without phenol func-
tionality (2 j), albeit in low yield.
Alternative 3-aryl-oxetan-3-ol substrates were prepared (5–
10), each with a para-donating aromatic groups (see the Sup-
porting Information). Using either catechol or 2-methylphenol
gave the desired oxetane products in each case (11–14) in 33–
77% yields. Importantly, heterocycles were also suitable as the
preinstalled aromatic group. 2-Methylfuran was capable of sta-
bilizing the carbocationic intermediate affording oxetane 15 in
58% yield, providing another functionalizable handle. Further-
more, indole-containing oxetanes 16a and 16b were formed
in high yields under the same conditions. As such, by using
a combination of different nucleophiles and preinstalled aryl
groups a variety of 3,3-diaryl-oxetanes can be rapidly prepared,
with attractive functionality for further elaboration.
The dihydrobenzofuran product 3a would exhibit the diaryl
motif in an alternative defined orientation and represented an
interesting compound in its own right. This scaffold is present
in a multitude of natural products and synthetic compounds
including marketed drugs with wide ranging biological activi-
ty.[23,24] The intramolecular ring opening of oxetane products to
generate other heterocycles has received interest in recent
years,[25] including the formation of certain dihydrobenzofuran
derivatives.[26] Herein little studied 3-aryl-3-hydroxymethyl-dihy-
drobenzofurans are prepared in a short sequence,[27] whereby
oxetan-3-one functions as a ‘triple electrophile’ over 2 steps.
We anticipated that blocking the phenol para-position
would afford these products exclusively, which was proven cor-
rect (Scheme 3). Dihydrobenzofurans were prepared using
a wide selection of para- and meta-substituted phenols and re-
lated compounds. para-Substituted phenols (4k–o) were suc-
cessful using an extended reaction time of 20 h. As with the
oxetane products, more electron donating substituents gave
good yields, and lower yields for halide substituted examples.
A 98% yield of sesamol derivative 3q was obtained, formed as
a single regioisomer. 3-Methoxyphenol also gave exclusively
the dihydrobenzofuran product 3r, the steric difference be-
tween hydroxy and methoxy proving sufficient to completely
prevent addition at the 4-position of the phenol. Resorcinols
proved to be good substrates forming the dihydrobenzofuran
products exclusively in yields of 67–74% (3s–v). With 5-meth-
Scheme 2. Scope of 3,3-diaryloxetanes using ortho-substituted phenols.
Scheme 3. Scope of dihydrobenzofurans using meta and para-substituted
phenols. [a] Reaction time of 20 h unless stated. [b] Reaction time of 1 h.
[c] Reaction time of 6 h.
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ylresorcinol, a mixture of dihydrobenzofuran regioisomers
were obtained in 73% combined yield (3w and 3w’). 2-Nap-
thol derivatives gave excellent yields of single regioisomers of
derivatives 3x and 3y. Substrates in which the preinstalled aro-
matic group was varied were successful upon reaction with p-
methylphenol to give dihydrobenzofuran derivatives 17–21.
Only a small selection of meta-substituted phenols gave rise
to mixtures of product types, with the product ratio affected
by the bulk of the meta-substituent and the presence of an ad-
ditional ortho-substituent (Scheme 4). Importantly the structur-
al isomers were readily separable in each case. With 3-methyl-
phenol as the nucleophile, dihydrobenzofuran 3z was formed
as the major product yield (2z :3z ;1:2) in 86% combined yield.
2,3-Dimethylphenol led to 3,3-diaryloxetane 2aa as the major
product. The reaction with 3-fluorophenol showed a slight
preference for oxetane 2ab, and dihydrobenzofuran 3ab was
formed as a mixture of 6-F and 4-F isomers.
With a selection of 3,3-diaryloxetanes available, we demon-
strated the removal of the benzyl group to reveal the phenol
functionality. Simple hydrogenolysis of 2a using Pd/C under H2
gave oxetane 22 in quantitative yield (Scheme 5). Oxetane 22
is a novel derivative of BPA, in which the gem-dimethyl is
linked with an oxygen atom, which may present interesting
properties as a BPA alternative.
To exploit the phenol functionality, the derivatization of oxe-
tane 2a was explored through a range of reactions, intended
to demonstrate the stability of the oxetane unit. Alkylation by
ring opening of 1,1-dimethyloxirane under basic conditions
gave oxetane 23 in 77% yield. Copper-catalyzed Ullmann cou-
plings proceeded in good yields with both 1-iodo-3,5-dime-
thylbenzene and 2-iodopyridine (24 and 25),[28] indicating
good stability of the oxetane over extended reaction times at
elevated temperatures. Conversion of oxetane 2a to triflate 26
was successful under standard conditions (Tf2O, pyridine).
From triflate 26, palladium-catalyzed deoxygenation afforded
phenyl substituted oxetane 27 (X=H).[29] Buchwald–Hartwig
amination gave morpholine substituted oxetane 28 in an ex-
cellent 94% yield.[30] Finally, Suzuki–Miyaura cross-coupling
using Pd(OAc)2 and SPhos gave biaryl 29.
Mechanistically, we propose a catalytic cycle involving initial
activation of the Li(NTf2) pre-catalyst through disruption of the
tetrahedrally coordinated solid-state lattice,[31] aided by the am-
monium salt additive (Scheme 6). Coordination and activation
of the tertiary-hydroxy group is likely to generate the key car-
bocationic intermediate. Addition of phenol through the para-
or ortho-position would generate intermediates 30 or 31, re-
spectively (boxed). From intermediate 30, rearomatization
would yield the 3,3-diaryloxetane product 2a, with a loss of
water regenerating the catalyst. Conversely, if ortho-addition
into the carbocation occurs, rearomatization and coordination
of the Lewis acid catalyst to the oxetane oxygen initiates intra-
molecular cyclization to dihydrobenzofuran 3a. This is rapid
and the ortho-substituted diaryloxetane was not observed in
any dihydrobenzofuran forming example. On this path, the Li
catalyst displays selective sequential activation of the hydroxy
group for Friedel–Crafts alkylation and then activation of the
oxetane to ring opening.
Scheme 4. Some meta-substituted phenols gave separable mixtures of oxe-
tane and dihydrobenzofuran products. [a] Formed as a mixture of 6-F and 4-
F dihydrobenzofurans (85:15).
Scheme 5. Derivatization of 3,3-diaryloxetane 2a. a) Pd/C (10%w/w), H2
(1 atm), EtOH, 0.1m, 25 8C, 14 h. b) 1,1-Dimethyloxirane, K2CO3, DMF, 0.5m,
100 8C, 16 h. c) 5-Iodo-m-xylene, CuI (5 mol%), N,N-dimethylglycine.HCl
(18.5 mol%), Cs2CO3, dioxane, 0.5m, 90 8C, 20 h. d) 2-iodopyridine, CuI
(5 mol%), picolinic acid (10 mol%), K3PO4, DMSO, 0.5m, 90 8C, 23 h. e) Tf2O,
pyridine, CH2Cl2, 0.5m, 25 8C, 2 h. f) Pd(OAc)2 (2 mol%), 1,1’-ferrocenediyl-
bis(diphenylphosphine) (=dppf) (2 mol%), Et3N, HCO2H, DMF, 0.5m, 60 8C,
1 h. g) Morpholine, Pd(OAc)2 (1 mol%), JohnPhos (2 mol%), K3PO4, THF,
0.5m, 65 8C, 24 h. h) 4-Cyanoboronic acid, Pd(OAc)2 (5 mol%), SPhos
(10 mol%), K3CO3, THF, 0.5m, 65 8C, 18 h.
Scheme 6. Proposed catalytic cycle.
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Conclusion
We have developed a rapid approach to 3,3-diaryloxetane and
2,3-dihydrobenzofuran scaffolds through a Friedel–Crafts reac-
tion on oxetanols with phenols, using an inexpensive and
widely available lithium catalyst. The reaction is divergent to
give the two heterocyclic classes which can be accessed with
complete selectivity dependent on the ortho- or para-regiose-
lectivity of the phenol substrates. We present successful condi-
tions for the efficient synthesis of 3,3-diaryloxetanes, the first
examples of this motif, designed as an isostere for diarylme-
thanes and diaryl ketones. High yields were achieved using
ortho-substituted phenols and related derivatives, with com-
plete selectivity for the 3,3-diaryloxetane product observed. Re-
markably, the lithium catalyst for the Friedel–Crafts reaction se-
lectively activates the tertiary-hydroxy group of oxetan-3-ols
without being impeded by coordination to other oxygen con-
taining species present, and without causing ring opening or
polymerization of the oxetanes. Furthermore, good reactivity
and stability of the products to a number of synthetically
useful transformations such as alkylation, deoxygenation and
metal-catalyzed cross-coupling reactions, was demonstrated,
suitable for their use in medicinal chemistry programs. In all
cases the oxetane derivatives showed very high stability to the
reaction conditions. Under the same conditions, ortho-selective
alkylation afforded the synthesis of dihydrobenzofurans, also
a biologically important motif, by one-pot Friedel–Crafts alkyla-
tion and oxetane ring opening. The use of meta- and para-sub-
stituted phenols, resourcinols and 2-napthol derivatives ena-
bled formation of these novel scaffolds in high yields. Both
product classes present novel substitution patterns on the O-
heterocycles and a wide scope of derivatives is prepared. The
reaction likely proceeds via an unusual carbocationic inter-
mediate on the oxetane ring formed through selective activa-
tion of the hydroxyl group of oxetan-3-ols. Future studies on
the properties of the 3,3-diaryloxetanes, and application to
other ring systems will be reported in due course.
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Structurally Divergent Lithium
Catalyzed Friedel–Crafts Reactions on
Oxetan-3-ols: Synthesis of 3,3-
Diaryloxetanes and 2,3-
Dihydrobenzofurans
Double the benefit : 3,3-Diaryloxetanes
are prepared as isosteres of benzophe-
nones and diarylmethanes, through in-
expensive lithium catalyzed Friedel–
Crafts reaction (see figure). Complemen-
tary dihydrobenzofurans are also pre-
pared, highly selectively, with the prod-
uct dependent on the substrate regiose-
lectivity. The oxetane products are
stable to further derivatization reactions,
suitable for incorporation into drug dis-
covery efforts.
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